NetworkNewsBreaks

ThursdayMay 05, 2022 2:07 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads, “Seven years ago yesterday, on Star Wars Day, Knightscope deployed its first robot at a popular Silicon Valley mall — an expanding use case with proven, ongoing successes. Protecting large parking lots and structures by enhancing existing security operations with a K5 Autonomous Security Robot (‘ASR’) helps to deter common challenges among mall owners and management companies such as trespassers, criminal mischief, and catalytic converter…

Continue Reading

ThursdayMay 05, 2022 1:56 pm

NetworkNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Announces Update on Installation of One of Illinois’ Largest Rooftop Solar Power Facilities

Correlate Infrastructure Partners (OTCQB: CIPI) today announced that final engineering, permitting and interconnection work has begun on the Geneva, Illinois, facility where the company has contracted to install a large-scale rooftop solar project. The massive project is being constructed at the headquarters of Continental Envelope and is located at the company’s manufacturing plant, which has the capacity to produce 2 billion envelopes per year. The clean energy system complements Continental’s “Pushing the Envelope” Community Gardens surrounding the property. “Correlate Infrastructure Partners loves supporting ESG-focused businesses that are making a true difference in their industries and communities. This attractive project makes…

Continue Reading

ThursdayMay 05, 2022 1:20 pm

NetworkNewsBreaks – SPYR Technologies’ (SPYR) Applied Magix Considers Developing Commercial Software to Support Non-Branded Products

SPYR (OTCQB: SPYR) is a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The company today announced that it is considering developing software for non-branded smart products in order to improve the user experience (“UX”), enhancing available products without the burden of new hardware development. “In our research into viable products to manufacture or carry, we have come across a number of manufacturers in China, with well-engineered, often excellent hardware, yet abysmally poor software. Since the software is the main point of interaction for…

Continue Reading

ThursdayMay 05, 2022 12:47 pm

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Featured on Success Story Podcast

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its cofounder and CEO Matt Stang were spotlighted in a recent episode of The Success Story podcast. During the interview, Stang talked all things Delic, including a history of the company, his decision to pivot from a career in cannabis to psychedelics, and what he believes the future holds for the company. “When we created [Delic], it was really under the supposition that a tipping point was coming for psychedelics the way it had come for cannabis,” said Delic Holdings…

Continue Reading

ThursdayMay 05, 2022 12:35 pm

NetworkNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster presentation at the “From Research to Reality” Global Summit on Psychedelic-Assisted Therapies and Medicines. The event is slated to take place from May 27-29, 2022, in Toronto, Canada. “It is an honor to participate in this inaugural conference devoted to psychedelic-assisted therapy and to be part of the rigorous scientific work being done in the field,” said Doug Drysdale, chief executive officer of Cybin. “The…

Continue Reading

ThursdayMay 05, 2022 12:20 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) to Show High-Performance FIVE RS during Roadshow Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that it will be adding its Mullen FIVE RS model to its summer roadshow tour. The company has been touring the country in what it calls a “strikingly different” test-drive opportunity. The event has featured the Mullen FIVE EV Crossover; adding the Mullen FIVE RS will allow those who visit the event to see the new electric vehicle up close although, because of its high-powered capabilities (it can go from 0 to 60 mph in 1.95 seconds), visitors will not be able to test drive the car. Rather,…

Continue Reading

ThursdayMay 05, 2022 11:49 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid study to assess the effects of delta-9 (“d-9”) dominant tetrahydrocannabivarin (“THCV”) on energy, focus/attention, appetite and weight/BMI. According to the update, BayMedia will be supplying its highly pure d-9 dominant THCV, formulated into a proprietary lozenge manufactured by Trokie. “We are excited to be part of this groundbreaking study with Trokie and Radicle Science in advance of our commercial launch…

Continue Reading

WednesdayMay 04, 2022 3:13 pm

NetworkNewsBreaks – IBN’s BioMedWire to Raise Visibility of 2nd Annual Gene Therapy Patient Engagement Summit

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands including BioMedWire (“BMW”), today announced that it will be collaborating with Hanson Wade as an official media sponsor for the upcoming 2nd Annual Gene Therapy Patient Engagement Summit. The event is slated to take place from June 7-9, 2022, in Boston, Massachusetts, and unite patient advocacy groups, engagement leaders and the patients themselves to provide insight and honest discussions. During the three-day summit, presentations will be held on a variety of topics, including managing expectations of gene therapy across stakeholders, incorporating the latest regulatory guidelines on patient…

Continue Reading

WednesdayMay 04, 2022 3:05 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Executes on Collaborative Cannabis Cultivation Model

Sugarmade (OTC: SGMD), an emerging company in the licensed cannabis sector, today announced its first transaction relative to its collaborative cannabis cultivation strategy via a definitive and executed contract with Cannabis Global Inc. (OTC: CBGL). Under the agreement, Sugarmade, via partner licensed and permitted Lake County, California, cannabis cultivators, will produce approximately 25,000 pounds of “Fresh Frozen” cannabis, which Cannabis Global will use in its product lines and distribute to the California marketplace. “As we recently announced to our shareholders, we see a strong business model of utilizing now idle resources of other California cultivators who have decided they can…

Continue Reading

WednesdayMay 04, 2022 2:56 pm

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Ketamine Wellness Centers Now Offer NAD+ Infusion Therapy

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and its Ketamine Wellness Centers (“KWC”)  are now offering  NAD+ infusion therapy at six clinic locations. KWC is the largest ketamine therapy provider in the country to offer the therapy, which is administered intravenously or intramuscularly. According to the company, the treatment can boost natural energy stores and immunity, along with brain and DNA function as well as cell communication; the treatment can also facilitate the healing chronic conditions such as depression, PTSD and anxiety. The treatment will be available at…

Continue Reading